Comparison of Classification of Indications for Allogeneic and Autologous Transplant for Adults in ASTCT Guidelines and Evidence Available in Published Literature-Reference-Cited by-同舟云学术

Comparison of Classification of Indications for Allogeneic and Autologous Transplant for Adults in ASTCT Guidelines and Evidence Available in Published Literature

Published:2022-01-01 Issue:1 Volume:182 Page:76
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Kim Myung S.¹,Cai Johnny²,Maniar Ashray³,Kartika Thomas²,Haslam Alyson⁴,Prasad Vinay⁴⁵

Affiliation:

1. Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland

2. Division of Internal Medicine, Oregon Health and Science University Portland

3. Division of Hematology Oncology, Columbia University, New York, New York

4. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco

5. Department of Medicine, University of California, San Francisco, San Francisco

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2783804/jamainternal_kim_2021_ld_210050_1640813867.65389.pdf

Reference4 articles.

1. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.;Eddy;J Clin Oncol,1992

2. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.;Stadtmauer;N Engl J Med,2000

3. Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy.;Kanate;Biol Blood Marrow Transplant,2020

4. Center for International Blood and Marrow Transplant Research Transplant Activity Report Covering 2013-2017. Health Resources & Services Administration website. Updated October, 2020. Accessed April 7, 2021. https://bloodstemcell.hrsa.gov/data/donation-and-transplantation-statistics/transplant-activity-report

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors;Transplantation and Cellular Therapy;2023-06

2. Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection;Journal of Clinical Medicine;2022-04-11

3. Everyone is entitled to his or her own opinion but not to their own facts*;British Journal of Haematology;2022-01-17

4. Transplant indications, guidelines and recommendations: Caveat Emptor;Bone Marrow Transplantation;2021-10-28

5. Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia?;Haematologica;2021-10-14